1801 — Innovent Biologics Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareSpeculativeLarge CapHigh Flyer

Annual balance sheet for Innovent Biologics, fiscal year end - December 31st, CNY millions except per share, conversion factor applied.

	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st	2025 December 31st
Period Length:	—	—	—	—	—
Source:	ARS	ARS	ARS	ARS	PRESS
Standards:	IFRS	IFRS	IFRS	IFRS	—
Status:	Final	Final	Final	Final	Final
Cash
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	7,948	8,265	10,120	7,750	18,231
Net Total Accounts Receivable
Net Total Receivables	968	575	1,006	1,184	1,714
Total Inventory
Prepaid Expenses
Total Other Current Assets
Total Current Assets	11,551	11,507	13,428	10,273	22,013
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	3,376	4,061	4,852	5,794	5,464
Net Intangible Assets
Long Term Investments
Long Term Notes Receivable
Other Long Term Assets
Total Assets	16,244	17,589	20,627	21,603	37,348
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	3,050	3,499	4,477	4,369	8,387
Long Term Debt
Capital Lease Obligations
Total Long Term Debt
Total Debt
Total Other Liabilities
Total Liabilities	5,913	6,859	8,100	8,485	17,992
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Unrealized Gain / Loss
Other Equity
Total Equity	10,330	10,730	12,528	13,118	19,356
Total Liabilities & Shareholders' Equity	16,244	17,589	20,627	21,603	37,348
Total Common Shares Outstanding